Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06809023 · ClinicalTrials.gov registry record · NA
Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment
A NA study, sponsored by Brigham and Women's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06809023: Clinical Trial NA study, sponsored by Brigham and Women's Hospital.
NCT06809023 is a NA study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06809023, a NA study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to learn whether insufficient sleep affects glucose metabolism differently in healthy men and women.
Primary Outcome
Test the hypothesis that three nights of sleep curtailment increases postprandial glucose levels to a greater extent in women compared to men. Postprandial glucose will be assessed in response to a standard meal after Control and Sleep Restriction. The change in postprandial glucose from Control to Sleep Restriction will be compared between men and women.
Interventions
- BEHAVIORAL Sleep restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-04 |
| Est. Completion | 2029-02 |
| Phase | NA |
What is known before NCT06809023 opens enrollment
NCT06809023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Sleep restriction is the first listed.
NCT06809023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06809023 about?
NCT06809023 is a clinical study titled "Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment". The goal of this study is to learn whether insufficient sleep affects glucose metabolism differently in healthy men and women.
What is the current status of trial NCT06809023?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-04. Estimated completion is 2029-02.
What interventions are being tested in trial NCT06809023?
The interventions under investigation include: Sleep restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06809023?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06809023's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia